Targeting TPO/MPL Signaling to Mitigate JAK2V617F-driven Cardiac Microvascular Disease
Xiaoxi Yang, Kyla Masarik, Xiaochuan Sun, Fangfang Zhang, Kirsten Zheng, Haoyi Zheng, Huichun Zhan
This study shows that JAK2V617F-mutant hematopoiesis causes cardiac microvascular disease, and blocking MPL signaling in endocardial endothelial cells improves cardiac function.
bioRxiv · Apr 3, 2026 · PreprintCell Biology